InsiderTrades.com logo

CLYM Insider Trading

Insider Ownership Percentage: 0.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $5,605.47

Climb Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Climb Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Climb Bio Share Price & Price History

Current Price: $1.73
Price Change: ▼ Price Decrease of -0.01 (-0.57%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for CLYM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Climb Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/20/2025Emily PimblettCAOSell1,242$1.24$1,540.0818,888View SEC Filing Icon  
3/20/2025Emily PimblettCAOSell1,199$1.31$1,570.6915,130View SEC Filing Icon  
12/19/2024Emily PimblettCAOSell1,235$2.02$2,494.7011,329View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Climb Bio (NASDAQ:CLYM)

69.76% of Climb Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CLYM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Climb Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Susquehanna International Group LLP142,450$0.29M0.0%+128.4%0.209%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC40,718$82K0.0%N/A0.060%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC471,704$0.95M0.0%-1.7%0.692%Search for SEC Filing on Google Icon
11/14/2025Deep Track Capital LP509,789$1.03M0.0%-51.0%0.748%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC133,530$0.27M0.0%+11.9%0.196%Search for SEC Filing on Google Icon
11/14/2025Shay Capital LLC150,000$0.30M0.0%-63.9%0.220%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP112,681$0.23M0.0%-37.3%0.165%Search for SEC Filing on Google Icon
11/14/2025Bridgeway Capital Management LLC109,300$0.22M0.0%-18.6%0.160%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG405,404$0.82M0.0%+6.0%0.595%Search for SEC Filing on Google Icon
11/10/2025Peapod Lane Capital LLC561,866$1.13M1.0%+1.1%0.824%Search for SEC Filing on Google Icon
11/10/2025Persistent Asset Partners Ltd28,221$57K0.0%-80.6%0.041%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.1,315,811$2.65M0.0%-1.2%1.942%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.22,012$44K0.0%-89.5%0.032%Search for SEC Filing on Google Icon
10/31/2025Vanguard Personalized Indexing Management LLC14,546$29K0.0%N/A0.021%Search for SEC Filing on Google Icon
10/24/2025Citizens Financial Group Inc. RI46,000$92K0.0%N/A0.068%Search for SEC Filing on Google Icon
8/15/2025Shay Capital LLC415,000$0.52M0.1%+107.5%0.612%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC148,180$0.18M0.0%N/A0.219%Search for SEC Filing on Google Icon
8/14/2025Diadema Partners LP702,135$0.87M0.3%+4.8%1.039%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd34,310$43K0.0%N/A0.051%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP36,738$46K0.0%N/A0.054%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC116,147$0.14M0.1%N/A0.172%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.210,122$0.26M0.0%-31.4%0.311%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC311,721$0.39M0.0%-53.7%0.461%Search for SEC Filing on Google Icon
8/8/2025Nan Fung Trinity HK Ltd.463,654$0.58M0.1%N/A0.686%Search for SEC Filing on Google Icon
8/1/2025Y Intercept Hong Kong Ltd127,952$0.16M0.0%N/A0.189%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.120,742$0.15M0.0%N/A0.179%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.120,742$0.15M0.0%N/A0.179%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC21,808$27K0.0%N/A0.032%Search for SEC Filing on Google Icon
5/16/2025Allostery Investments LP244,988$0.30M0.4%N/A0.363%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC119,320$0.15M0.0%N/A0.177%Search for SEC Filing on Google Icon
5/15/2025RA Capital Management L.P.31,419,267$38.33M0.6%N/A46.495%Search for SEC Filing on Google Icon
5/14/2025Affinity Asset Advisors LLC1,500,000$1.83M0.2%N/A2.220%Search for SEC Filing on Google Icon
5/13/2025Persistent Asset Partners Ltd145,760$0.18M0.1%N/A0.216%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC39,034$48K0.0%N/A0.058%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.70,093$86K0.0%N/A0.104%Search for SEC Filing on Google Icon
5/8/2025XTX Topco Ltd27,660$34K0.0%N/A0.041%Search for SEC Filing on Google Icon
5/7/2025TD Asset Management Inc89,400$0.11M0.0%N/A0.132%Search for SEC Filing on Google Icon
4/30/2025Peapod Lane Capital LLC553,816$0.68M0.8%N/A0.821%Search for SEC Filing on Google Icon
4/29/2025Bank of New York Mellon Corp64,914$79K0.0%N/A0.096%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Climb Bio logo
Climb Bio Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company's lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody which has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. Climb Bio Inc., formerly known as Eliem Therapeutics Inc., is based in WELLESLEY, Mass.
Read More on Climb Bio

Today's Range

Now: $1.73
Low: $1.71
High: $1.77

50 Day Range

MA: $1.92
Low: $1.64
High: $2.32

52 Week Range

Now: $1.73
Low: $1.05
High: $3.21

Volume

257,559 shs

Average Volume

333,925 shs

Market Capitalization

$117.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Climb Bio?

Climb Bio's top insider shareholders include:
  1. Emily Pimblett (CAO)
Learn More about top insider investors at Climb Bio.

Who are the major institutional investors of Climb Bio?

Climb Bio's top institutional investors include:
  1. Vanguard Group Inc. — 1.94%
  2. Peapod Lane Capital LLC — 0.82%
  3. Deep Track Capital LP — 0.75%
  4. Millennium Management LLC — 0.69%
  5. UBS Group AG — 0.59%
  6. Shay Capital LLC — 0.22%
Learn More about top institutional investors of Climb Bio stock.

Which major investors are selling Climb Bio stock?

In the previous quarter, CLYM stock was sold by these institutional investors:
  1. Deep Track Capital LP
  2. Shay Capital LLC
  3. JPMorgan Chase & Co.
  4. Persistent Asset Partners Ltd
  5. Two Sigma Investments LP
  6. Bridgeway Capital Management LLC
  7. Vanguard Group Inc.
  8. Millennium Management LLC

Which major investors are buying Climb Bio stock?

In the last quarter, CLYM stock was acquired by institutional investors including:
  1. Susquehanna International Group LLP
  2. Citizens Financial Group Inc. RI
  3. Prelude Capital Management LLC
  4. UBS Group AG
  5. Vanguard Personalized Indexing Management LLC
  6. ADAR1 Capital Management LLC
  7. Peapod Lane Capital LLC